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Abstract 
Low allergy-related disease (ARD) prevalence in low-income countries may be partly 
attributed to helminth infections. In the Schistosoma mansoni (Sm)-endemic Lake 
Victoria islands (Uganda), we recently observed positive helminth-allergy 
associations, despite low ARD prevalence. To understand how Sm-induced cytokine 
and antibody profiles might influence allergic response profiles in this population, we 
assessed Schistosoma worm (SWA)- and egg antigen (SEA)-specific Th1 (IFN-γ), 
Th2 (IL-5, IL-13) and regulatory (IL-10) cytokine profiles (n=407), and total (n=471), 
SWA-, SEA- and allergen (house dust mite [HDM] and cockroach)-specific (as)IgE 
and IgG4 profiles (n=2117) by ELISA. Wheeze was inversely associated with SWA-
specific IFN-γ (p<0.001) and IL-10 (p=0.058), and SEA-specific IL-5 (p=0.004). 
Conversely, having a detectable asIgE response was positively associated with 
SWA-specific IL-5 (p=0.006) and IL-10 (p<0.001). Total, SWA-, SEA- and allergen-
specific IgE and IgG4 responses were higher among Sm Kato-Katz positive (SmKK+) 
and skin prick test (SPT)+ individuals compared to SmKK- and SPT- individuals. 
However, total and asIgG4/IgE ratios were lower among SPT+ and wheezing 
individuals. We conclude that, in this population, helminth-induced antibody and 
cytokine responses may underlie individual positive helminth-atopy associations, 
while the overall IgG4-IgE balance may contribute to the low overall prevalence of 
clinical allergies in such settings. 
  
Key words: Schistosoma spp, allergy, cytokine, immunoglobulin, ELISA  
 
Introduction 
Helminths have a small range of antigens that are strikingly homologous to common 
allergens.1 These antigens induce immunoglobulin (Ig) E-mediated effector 
responses important for protection against helminth infection.2,3 To survive in the 
host, helminths modulate this atopic pathway, and this may have a bystander 
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protective effect against allergy-related disease (ARD).4 While several animal and 
human studies provide compelling evidence of this protection,5,6 others suggest that 
in some circumstances helminths may actually promote enhanced responses to 
allergens.7,8 
Mechanisms underlying helminth-allergy associations in low-income countries (LICs) 
are not fully understood. Hypothesised pathways that underpin these associations 
are shown in Figure 1. Helminth-induced cytokine and antibody profiles may 
influence allergic responses, and consequently epidemiological trends pertaining to 
ARDs.5,9 Both helminth- and allergen-specific immune responses are characterised 
by elevated Th2-type responses (interleukin [IL]-4, IL-5 and IL-13).10,11 Helminths, 
unlike allergens, further induce strong immunoregulation epitomised by IL-10 
production.12 Typically, these cytokines influence the profile of antibodies involved in 
helminth infection and allergy. Helminth-induced IL-10 may drive immunoglobulin 
class switching to IgG413,14 which, akin to the Th2 cytokine-induced15 polyclonally 
stimulated IgE, may inhibit development of allergen-specific effector responses,5,16 
leading to inverse helminth-allergy associations. Conversely, helminth-induced 
protein-specific IgE may promote strong, cross-reactive helminth- and allergen-
specific responses, resulting in positive helminth-allergy associations.17,18 
Emerging epidemiological data on helminth-allergy associations in Uganda reflect the 
complex interaction between helminths and allergens: while observational analyses 
in a birth cohort suggested a protective effect of childhood and maternal helminths 
against childhood eczema19 that was reversed by maternal anthelminthic treatment,20 
we recently reported positive helminth-allergy associations in a survey conducted in 
the Schistosoma mansoni (Sm)-endemic Lake Victoria islands, albeit against a 
backdrop of low ARD prevalence.21 To establish how Sm-induced cytokine and 
antibody profiles underpinned helminth-allergy associations in the above survey, we 
here describe an assessment of Sm-specific cytokine profiles, as well as total, 
allergen- and Sm-specific IgE and IgG4 profiles, and their relationship with Sm 
infection status, wheeze and atopy. 
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Methods 
Study population 
Samples were collected during the baseline household survey preceding a cluster-
randomised trial of standard versus intensive anthelminthic intervention (the Lake 
Victoria Island Intervention Study on Worms and Allergy-related diseases, 
LaVIISWA; ISRCTN47196031) described elsewhere.21,22 Briefly, each consenting 
LaVIISWA participant completed a questionnaire, provided blood, urine and stool and 
underwent skin prick testing (SPT). Primary allergy-related outcomes were reported 
wheeze in the previous 12 months and atopy. Wheeze is widely used as a surrogate 
for asthma in epidemiological studies,23 and was assessed for all ages using the 
International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire. 
Such symptom questionnaires have been identified as the best way to estimate 
asthma prevalence in epidemiological studies.23 The ISAAC questionnaire was used 
to ask participants (or their caregivers) if they had ever wheezed and if so, if they had 
wheezed in the last 12 months. Details on aetiology were not collected. Atopy was 
defined as 1) SPT reactivity to any of Dermatophagoides mix, Blomia tropicalis or 
German cockroach (Blattella germanica) [ALK-Abelló; supplied by Laboratory 
Specialities Ltd., South Africa], and 2) detectable IgE response (>312ng/ml by 
ELISA21) to Dermatophagoides pteronyssinus [hereinafter ‘house dust mite (HDM)’] 
and/or German cockroach whole allergen extracts (Greer Labs, U.S.A).  
Ethics committees of Uganda Virus Research Institute, London School of Hygiene 
and Tropical Medicine and Uganda National Council for Science and Technology 
approved the study.  
 
Laboratory methods 
Two slides from one stool sample per individual were independently examined by 
different technicians for Sm eggs using the Kato-Katz method.24  
We assessed IFN-γ (Th1-type), IL-5, IL-13 (Th2-type) and IL-10 (regulatory) levels by 
ELISA using supernatants from six-day whole blood cultures stimulated with 
Schistosoma worm (SWA) and egg antigens (SEA), as previously described.25 
Briefly, heparinised blood was diluted with RPMI 1640 medium (Life technologies, 
UK) supplemented with penicillin, streptomycin, glutamine and Hepes buffer (all from 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Life technologies, UK), plated in 96-well culture plates and stimulated (at 370C, 5% 
CO2) with 10μg/ml SWA or SEA (provided by Professor Mike Doenhoff, University of 
Nottingham) or mitogen (phytohaemagglutinin, PHA, Sigma, UK), or left 
unstimulated. Supernatants were harvested on day six and stored at -800C until 
analysis. Cytokine levels in supernatants were measured by ELISA (Becton 
Dickinson, USA). The net response to each stimulus was calculated by subtracting 
the concentration in the unstimulated control well. Response values that were below 
the dynamic range of the assay and those that were negative after subtraction of the 
response in the unstimulated well were assigned a value of zero. 
HDM and cockroach extract-specific IgE and IgG4 were measured in plasma using 
an in-house ELISA described previously.20 Briefly, MICROLON® 96-well plates 
(Greiner bio-one, UK) were coated overnight at 40C with 5μg/ml HDM or cockroach 
allergens and two-fold dilutions of human IgE (Calbiochem, Beeston, UK) or IgG4 
(Sigma-Aldrich) standards. Plates were blocked at room temperature (RT) with 1% 
skimmed milk and incubated overnight at 40C with plasma samples diluted 1/20 (IgE 
assay) or 1/40 (IgG4 assay) with 10% fetal bovine serum in PBS-Tween 20. Specific 
IgE or IgG4 was detected using biotinylated monoclonal mouse anti-human IgE or 
IgG4 (BD Pharmingen™) and a streptavidin-Horseradish Peroxidase conjugate 
(Mast Group Ltd, Bootle, UK). O-phenylenediamine (Sigma-Aldrich) was used as a 
substrate, and the reaction stopped with 2M Sulphuric acid. Optical density values 
were measured at 490nm (reference wavelength 630nm) on a 96-well plate ELISA 
reader. IgE or IgG4 concentrations (ng/ml) were interpolated from standard curves 
using a five-parameter curve fit using Gen5 data collection and analysis software 
(BioTek Instruments Inc, Vermont, Winooski, USA).  
Total, SWA- and SEA-specific IgE and IgG4 ELISAs were performed using similar in-
house procedures (detailed in this article’s supporting information). 
 
Statistical methods 
Our hypothesised mode of action of S. mansoni-induced cytokines and antibodies on 
allergy-related outcomes is illustrated in Figure 1. Using STATA 13.1 (College 
Station, Texas, USA), we performed cross-sectional analyses to assess whether Sm 
Kato-Katz positivity and allergy-related outcomes were associated with antibody and 
cytokine levels, using the “svy” command to allow for the non-self-weighting cluster 
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survey design. Raw cytokine and antibody responses were skewed, so log10 
(concentration+1)-transformed antibody and cytokine data were used in our 
regression models; we back-transformed the results to obtain geometric mean ratios 
and 95% confidence intervals. Crude and age- and sex-adjusted analyses were 
performed. Associations between antibody responses were estimated using 
Spearman’s correlation coefficient (rs). We used a 5% significance level for all 
analyses. P values quoted in the main text are from adjusted analyses. 
 
Results  
Questionnaire data were obtained from 2316 participants.22 Their characteristics and 
those of participants for whom cytokine and antibody responses were assessed are 
shown in Table 1. Participants for whom cytokine (n=407) and total antibody levels 
(n=471) were assessed were a subset of participants who had allergen-, SWA- and 
SEA-specific antibody results (n=2117). Cytokine responses were assessed using 
samples from 1-17 year olds, to allow comparison with related cellular immunology 
studies in an urban birth cohort (data not shown). Allergen-, SWA- and SEA-specific 
responses were assessed in all survey participants that had sufficient plasma sample 
stored. 
S. mansoni-specific cytokines and allergy-related outcomes 
Individuals who tested positive for Sm by Kato-Katz (SmKK+) had higher geometric 
mean concentrations of SWA-specific type 2 and regulatory cytokines compared to 
SmKK- individuals (Table 2), but this was statistically significant only for IL-5 
(p=0.034). However, there was no dose-response relationship with infection intensity 
(supplementary Table S3A). SEA-specific responses were similar between SmKK+ 
and SmKK- individuals.  
Wheeze was inversely associated with SWA-specific IFN-γ (p<0.001) and IL-10 
(p=0.058; Table 2), and SWA-specific IL-10/IL-5 and SEA-specific IL-10/IFN-γ ratios 
(supplementary Table S1). Wheezing individuals also had lower mean SEA-specific 
cytokine responses, although statistical evidence for an inverse association was 
observed only for SEA-specific IL-5 (p=0.004).  
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Conversely, there was a crude positive association between SPT positivity and SWA-
specific IL-10 (p=0.048; Table 2); and individuals with detectable allergen-specific 
(as)IgE had higher SWA-specific IL-5 (p=0.006) and IL-10 responses (p<0.001; 
Table 2) and higher SWA- and SEA-specific IL-10/IFN-γ and IL-5/IFN-γ ratios (Table 
S1).  
 
Antibody responses, S. mansoni Kato-Katz positivity and allergy 
Kato-Katz positivity was strongly positively associated with SWA- and SEA-specific 
IgE and IgG4 (p<0.001), with HDM-specific IgE (p=0.006) and HDM- and cockroach-
specific IgG4 (p<0.001; Table 3 and supplementary Figure S1). However, 
correlations between Sm antigen-specific antibodies and allergen-specific antibodies 
were weak (rs<0.4, Table S2). 
Kato-Katz positivity was also strongly positively associated with total IgE (p<0.001) 
(Table 3 and Figure S1), which was in turn weakly correlated with SEA-specific IgE 
but moderately correlated with SWA-specific IgE (rs=0.31 and rs=0.51, respectively; 
Table S2). Similarly, total IgG4 (p<0.001), total IgG4/total IgE ratios (p=0.005) and 
total IgE/asIgE ratios (p<0.05) were positively associated with Kato-Katz positivity. In 
addition, there was a general dose-response relationship between S. mansoni 
infection intensity and antibody responses (supplementary Table S3B). 
Cockroach-specific IgE and total IgE were positively associated with cockroach SPT 
reactivity. HDM-specific IgE and IgG4, SWA- and SEA-specific IgE and total IgE, 
were all positively associated with HDM SPT reactivity (Table 3 and Figure S1).  In 
contrast, cockroach SPT reactivity was inversely associated with total IgG4/total IgE 
ratios (p=0.022), and HDM SPT reactivity with total IgE/HDM-specific IgE ratios 
(p<0.001).   
Associations between wheeze and antibody responses (Table 3 and Figure S1), 
when significant, were inverse. HDM IgG4/IgE ratios (p=0.032), cockroach-specific 
IgE (p=0.003) and cockroach-specific IgG4 (p=0.001) were all inversely associated 
with wheeze.  
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Discussion 
In this highly-Sm-endemic setting, associations between wheeze and Sm-specific 
cytokines and antibodies, when significant, were inverse. However, SPT reactivity 
and detectable asIgE were positively associated with the same Sm-specific 
responses.  
In this population, Sm exposure is almost universal, and infection much higher than 
indicated by Kato-Katz: urine assessment for Sm circulating cathodic antigen (CCA) 
indicated a prevalence of over 70%, compared to 51.4% prevalence by Kato-Katz.22 
Therefore, Kato-Katz negativity in many study participants was indicative of lighter 
(rather than absent) infection. This explains why, although SWA-specific Th2-type 
and regulatory cytokine responses were generally higher among SmKK+ individuals, 
only SWA-specific IL-5 reached significant levels, and why SEA-specific responses 
were similar between SmKK+ and SmKK- individuals. Further support for these 
observations comes from supplementary analysis (Table S4A), which shows that 
cytokine responses were similar between SmKK-CCA+ and SmKK+CCA+/- 
individuals.  
All statistically significant associations between atopy and Sm-specific cytokine 
responses were positive. Associations with whole blood cytokine responses are best 
interpreted taking into account total cell counts, but these data were unavailable. 
However, atopy-antibody associations were also positive. Besides, these results 
mirror our previous epidemiological observations in this population, where Sm 
infection was positively associated with Dermatophagoides-specific IgE, and atopy-
wheeze associations were stronger in presence of Sm infection.21  
Our results were unexpected in view of earlier findings from Gabon9 which showed 
an inverse association between dust mite SPT and SWA-specific IL-10 (albeit we 
used whole blood cultures, compared to peripheral blood mononuclear cells in the 
Gabon study). However, although IL-10 is chiefly immunomodulatory,26-28 it may also 
enhance IgE production in already IgE-switched B cells;13 these may be abundant in 
individuals from this helminth-endemic setting. SWA- and SEA-specific IgE were 
weakly positively associated with HDM SPT reactivity, perhaps unsurprisingly, as 
helminth antigens may induce cross-reactive helminth-and allergen-specific IgE 
effector responses. Total serum IgE, elevated during helminth infection mainly due to 
increased synthesis of polyclonal IgE, has been proposed to inhibit allergic 
responses.29,30 However, contrasting evidence links high serum IgE levels to 
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increased expression of IgE receptors on human basophils,31 and we show positive 
associations between total IgE and SPT reactivity to both cockroach and dust mite.  
In keeping with the original hypothesis, associations between wheeze and cytokine 
and antibody responses, when significant, were inverse. Furthermore, total and 
allergen-specific IgG4/IgE ratios were mostly inversely associated with atopy, 
implying that the regulatory role of IgG4 against allergy might best be assessed 
relative to IgE. Also, lower total/asIgE ratios among HDM SPT+ individuals are 
consistent with the perception that high total/asIgE ratios may be protective against 
allergic responses, because non-specific polyclonal IgE may compete with asIgE to 
saturate IgE receptors.29  
One limitation of assessing helminth-allergy associations and underlying 
mechanisms in this population is the almost universal exposure to helminths, and 
lack of data on duration of infection. We also report a large number of statistical 
tests, so some apparently “significant” findings could have occurred by chance.  
Since we anticipated that some of our measures might be correlated, we did not 
formally adjust for multiplicity, instead we focussed on patterns of association and 
consistency of results, and on biological plausibility with reference to other findings. 
Another potential limitation is that wheeze was relatively rare in the study population 
and hence some of our comparison groups (such as the age group 1-17 years) had a 
low prevalence. Besides, reported wheeze could easily be misclassified in this 
population due to lack of a direct translation of ‘wheeze’ in the native languages.21  
Nonetheless, our results generally agree with our epidemiological observations in the 
same population,21 where we found a very low prevalence of clinical allergies, 
despite positive helminth-atopy associations. 
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Legends to figures  
Figure 1.  
We hypothesise that the Th2 cytokine-induced Sm-specific IgE promotes potent, Sm-
specific, atopic effector responses and Sm elimination from the host, and also cross-
reactive responses to some allergens, resulting in positive Sm-allergy associations. 
By contrast, Sm-specific IL-10, IgG4 and/or non-specific polyclonally stimulated IgE 
inhibit these allergy-related outcomes. White and shaded arrows denote promotion 
and inhibition, respectively. 
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Table 1. Characteristics of participants 
Characteristic 
Survey population 
(N=2316), n/N (%) 
Immunological measure, n/N (%) 
  
Cytokine responses
‡ 
(N=407) 
Allergen-, SWA- and SEA-
specific IgE and IgG4
§ 
(N=2117) 
Total IgE and IgG4
¶ 
(N=471) 
Age in years, median (IQR) 24 (8, 32) 9 (6, 16) 25 (10, 33) 19.5 (3, 31.25) 
Male sex 1268/2316 (54.7) 168/407 (41.3) 1152/2117 (54.4) 225/471 (47.7) 
PZQ in last 12 months 382/2255 (16.9) 48/393 (12.2) 368/2062 (17.8) 15/459 (15.5) 
Helminth infections     
S. mansoni (KK) 1041/1996 (51.4) 204/373 (54.7) 1008/1882 (53.6) 184/428 (42.9) 
S. mansoni (urine CCA) 661/917 (72.0) 94/128 (73.4) 634/875 (72.5) 101/152 (66.5) 
S. mansoni intensity (KK) 
Uninfected 
Low 
Moderate 
Heavy 
 
995/1996 (48.6) 
429/1996 (21.0) 
288/1996 (13.7) 
324/1996 (16.6) 
 
169/373 (45.3) 
77/373 (20.6) 
56/373 (15.0) 
71/373 (19.0) 
 
874/1882 (46.4) 
411/1882 (21.8) 
279/1882 (14.8) 
318/1882 (16.9) 
 
244/428 (57.0) 
70/428 (16.4) 
51/428 (11.9) 
63/428 (14.7) 
Any nematode infection
†
  788/2004 (39.3) 129/373 (34.6) 738/1889 (39.1) 87/428 (20.3) 
Allergy-related outcomes     
Wheeze in last 12 months 107/2301 (4.7) 14/404 (3.5) 106/2103 (5.04) 58/468 (12.4) 
Atopy (SPT) 
Any 
Dermatophagoides 
 
404/1976 (19.1) 
190/1978 (9.0) 
 
78/372 (20.9) 
33/372 (8.9) 
 
403/1961 (20.6) 
189/1963 (9.6) 
 
135/448 (30.1) 
61/448 (13.6) 
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Blomia 
Cockroach 
205/1976 (9.6) 
272/1977 (13.2) 
31/372 (8.3) 
61/372 (16.4) 
204/1961 (10.4) 
272/1962 (13.9) 
67/447 (14.9) 
90/448 (20.1) 
Atopy (detectable asIgE) 
Any 
Dermatophagoides 
Cockroach 
 
1685/2117 (79.6) 
1534/2115 (72.5) 
886/2117 (41.9 
 
320/403 (79.4) 
278/403 (68.9) 
183/403 (45.4) 
 
1685/2117 (79.6) 
1534/2115 (72.5) 
886/2117 (41.9) 
 
358/471 (76.0) 
326/471 (69.2) 
186/471 (39.5) 
‡
Assessed using samples from 1-17 year olds, to allow comparison with related cellular immunology studies in an urban birth cohort (data not shown here). 
§
Assessed in all survey participants that had sufficient plasma sample stored. 
¶
Samples randomly selected from individuals with antigen-specific antibody data. 
†
Infection with any of Ascaris lumbricoides, Trichuris trichiura (assessed by KK), Necator americanus, Strongyloides stercoralis (assessed by PCR) and 
Mansonella perstans (assessed by modified Knott’s method). 
 
PZQ: Praziquantel treatment; KK: Kato-Katz; CCA: circulating cathodic antigen; SPT: skin prick test; SWA: Schistosoma worm antigen; SEA: Schistosoma 
egg antigen; asIgE: allergen-specific IgE 
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Table 2. Associations between S. mansoni-specific cytokine levels and i) S. mansoni 
infection status, ii) reported wheeze and iii) atopy (SPT reactivity and detectable 
allergen-specific IgE)   
    Unadjusted  Adjusted for age and sex 
Antigen Cytokine Geometric mean
†
  GMR (95% CI)
‡
 p value  GMR (95% CI)
 ‡
 p value 
 
 
SmKK- 
n=169 
SmKK+ 
n=204 
      
SWA  IFN-γ 1.16 1.13  1.06 (0.86, 1.30) 0.542  1.05 (0.87, 1.28) 0.531 
 
IL-5 14.92 49.47  1.43 (1.13, 1.81) 0.005  1.32 (1.02, 1.71) 0.034  
 
IL-13 7.01 17.56  1.20 (0.94, 1.54) 0.132  1.15 (0.88, 1.48) 0.282 
 
IL-10 3.99 11.58  1.21 (0.97, 1.51) 0.084  1.16 (0.91, 1.48) 0.207 
SEA  IFN-γ 0.73 0.56  0.97 (0.81, 1.17) 0.760  0.98 (0.82, 1.18) 0.884 
 
IL-5 5.02 3.11  0.84 (0.59, 1.19) 0.320  0.84 (0.58, 1.19) 0.319 
 
IL-13 2.25 1.95  0.86 (0.71, 1.05) 0.127  0.88 (0.73, 1.06) 0.190 
 
IL-10 3.19 4.42  0.93 (0.78, 1.13) 0.486  0.93 (0.76, 1.13) 0.477 
 
 
No wheeze 
n=390 
Wheeze 
n=14 
      
SWA IFN-γ 1.27 0.23  0.60 (0.45, 0.80) 0.001  0.57 (0.44, 0.76) <0.001 
 IL-5 29.12 27.59  1.29 (0.72, 2.33) 0.373  1.14 (0.63, 2.08) 0.657 
 IL-13 11.75 9.78  1.26 (0.65, 2.45) 0.465  1.17 (0.58, 2.36) 0.635 
 IL-10 7.91 2.03  0.69 (0.47, 1.01) 0.059  0.66 (0.43, 1.02) 0.058 
SEA IFN-γ 0.66 0.33  0.83 (0.66, 1.04) 0.101  0.83 (0.65, 1.05) 0.121 
 IL-5 4.37 1.20  0.52 (0.33, 0.83) 0.007  0.51 (0.33, 0.79) 0.004 
 IL-13 2.25 0.96  0.75 (0.44, 1.25) 0.256  0.76 (0.44, 1.33) 0.327 
 IL-10 4.34 0.59  0.70 (0.35, 1.38) 0.295  0.71 (0.37, 1.36) 0.291 
 
 
SPT- 
n=294 
SPT+
§
 
n=78 
      
SWA IFN-γ 1.03 1.73  1.15 (0.96, 1.36) 0.115  1.13 (0.94, 1.34) 0.178 
 
IL-5 29.23 39.73  1.15 (0.86, 1.52) 0.330  1.02 (0.75, 1.38) 0.897 
 
IL-13 13.54 10.32  0.99 (0.72, 1.36) 0.961  0.92 (0.67, 1.26) 0.596 
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IL-10 6.79 12.00  1.25 (1.00, 1.55) 0.048  1.21 (0.95, 1.54) 0.126 
SEA IFN-γ 0.55 0.99  1.11 (0.82, 1.51) 0.493  1.13 (0.83, 1.52) 0.423 
 IL-5 4.54 3.68  1.00 (0.70, 1.45) 0.965  0.98 (0.67, 1.43) 0.935 
 IL-13 2.81 1.09  0.84 (0.56, 1.25) 0.376  0.85 (0.58, 1.25) 0.413 
 IL-10 4.12 3.09  0.94 (0.76, 1.16) 0.560  0.96 (0.75, 1.22) 0.730 
 
 
Undetectable 
asIgE 
n=83 
Detectable 
asIgE
¶ 
n=320 
      
SWA IFN-γ 1.73 1.11  0.87 (0.62, 1.24) 0.444  0.86 (0.60, 1.23) 0.396 
 IL-5 16.44 34.25  1.43 (1.16, 1.75) 0.001  1.32 (1.09, 1.61) 0.006 
 IL-13 9.75 12.66  1.09 (0.77, 1.55) 0.599  1.04 (0.74, 1.47) 0.806 
 IL-10 3.76 9.26  1.34 (1.18, 1.51) <0.001  1.30 (1.16, 1.46) <0.001 
SEA IFN-γ 1.12 0.56  0.79 (0.56, 1.13) 0.190  0.79 (0.57, 1.11) 0.176 
 IL-5 3.78 4.17  1.13 (0.81, 1.58) 0.459  1.12 (0.82, 1.54) 0.450 
 IL-13 2.21 2.21  0.88 (0.65, 1.22) 0.449  0.90 (0.67, 1.21) 0.484 
 IL-10 3.49 4.17  1.05 (0.92, 1.21) 0.424  1.06 (0.93, 1.21) 0.382 
†
All cytokine concentrations in pg/ml.  
‡
Geometric mean ratios and 95% confidence intervals adjusted for the survey design.  
§
SPT reactivity to any one of Dermatophagoides mix, Blomia tropicalis or Blattella germanica.  
¶
Detectable IgE to either Dermatophagoides pteronyssinus or Blattella germanica.  
SmKK-: Kato-Katz negative result (S. mansoni), single stool sample; SmKK+: Kato-Katz positivity for S. mansoni, single 
stool sample; SPT: skin prick test; SWA: Schistosoma worm antigen; SEA: Schistosoma egg antigen; asIgE: allergen-
specific IgE; GMR: geometric mean ratio; 95% CI: 95% confidence interval. P values ≤0.05 are highlighted in bold. 
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Table 3. Associations between antibody (IgE and IgG4) levels and Kato-Katz 
positivity (S. mansoni), SPT reactivity and reported wheeze  
 
Antigen 
Antibody / 
antibody ratio 
Geometric mean
†
  aGMR (95% CI)
 ‡¶
 p value 
       
  SmKK- SmKK+    
       
SWA  IgE 1080 2433  1.54 (1.28, 1.84) <0.001 
 
IgG4 4031 27355  3.71 (3.14, 4.37) <0.001 
SEA  IgE 1412 1833  1.32 (1.15, 1.52) <0.001 
 
IgG4 18962 241763  5.51 (4.55, 6.67) <0.001 
House dust mite  IgE 0.782 10.678  1.25 (1.07, 1.45) 0.006 
 IgG4 0.001 0.192  1.79 (1.51, 2.13) <0.001 
 IgG4/IgE ratio 0.002 0.033  1.18 (0.58, 2.41) 0.629 
Cockroach IgE 18.8 19.2  1.00 (0.82, 1.22) 0.989 
 IgG4 0.002 0.292  1.50 (1.34, 1.68) <0.001 
 IgG4/IgE ratio 0.001 0.027  1.32 (0.94, 1.85) 0.110 
       
 Total IgE 969 3073  1.37 (1.22, 1.54) <0.001 
 
Total IgG4 51453 233745  1.94 (1.49, 2.52) <0.001 
 
Total IgG4/ 
total IgE ratio 
52.16 75.24  1.36 (1.11, 1.67) 0.005 
 
Total IgE/ 
cockroach IgE 
ratio 
3.79 12.60  1.32 (1.06, 1.66) 0.014 
 
Total IgE/ dust 
mite IgE ratio 
0.562 1.301  1.13 (1.02, 1.25) 0.016 
 
 
 
Cockroach 
SPT- 
Cockroach 
SPT+ 
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SWA  IgE 1704 1894  1.12 (0.94, 1.32) 0.173 
 
IgG4 12860 14155  1.04 (0.85, 1.28) 0.675 
SEA  IgE 1611 1876  1.12 (0.97, 1.29) 0.092 
 
IgG4 84831 101778  1.08 (0.92, 1.27) 0.319 
Dust mite  IgE 2.6 42.2  1.59 (1.35, 1.89) <0.001 
 IgG4 0.022 0.061  1.06 (0.87, 1.29) 0.498 
 IgG4/IgE ratio 0.009 0.001  0.56 (0.36, 0.85) 0.010 
Cockroach IgE 18.9 39.1  1.25 (1.08, 1.46) 0.004 
 IgG4 0.054 0.686  1.15 (0.95, 1.39) 0.129 
 IgG4/IgE ratio 0.003 0.017  0.69 (0.47, 1.02) 0.064 
       
 Total IgE 1462 2787  1.22 (1.05, 1.42) 0.011 
 
Total IgG4 90643 126688  0.84 (0.65, 1.07) 0.163 
 
Total IgG4/ 
total IgE ratio 
60.41 45.80  0.75 (0.58, 0.95) 0.022 
 
Total IgE/ 
cockroach IgE 
ratio 
6.07 9.22  1.01 (0.82, 1.25) 0.894 
 
Total IgE/ dust 
mite IgE ratio 
0.849 0.868  0.93 (0.84, 1.03) 0.140 
       
 
 
Dust mite 
SPT- 
Dust mite 
SPT+ 
   
       
SWA  IgE 1667 2409  1.26 (1.00, 1.57) 0.043 
 
IgG4 13088 12565  1.04 (0.79, 1.36) 0.744 
SEA  IgE 1623 1887  1.23 (0.99, 1.53) 0.055 
 
IgG4 85471 102026  1.20 (0.85, 1.68) 0.271 
Dust mite  IgE 2.5 242.9  2.10 (1.57, 2.81) <0.001 
 IgG4 0.020 0.245  1.41 (0.99, 1.99) 0.052 
 IgG4/IgE ratio 0.009 0.001  0.49 (0.23, 1.04) 0.064 
Cockroach IgE 19.9 33.7  1.21 (1.03, 1.43) 0.024 
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 IgG4 0.065 0.405  1.13 (0.85, 1.50) 0.395 
 IgG4/IgE ratio 0.004 0.013  0.71 (0.48, 1.04) 0.075 
       
 Total IgE 1533 2802  1.24 (1.03, 1.49) 0.025 
 
Total IgG4 89885 156204  1.09 (0.86, 1.38) 0.438 
 
Total IgG4/ 
total IgE ratio 
57.43 55.45  0.89 (0.72, 1.11) 0.292 
 
Total IgE/ 
cockroach IgE 
ratio 
6.41 8.11  1.01 (0.82, 1.26) 0.893 
 
Total IgE/ dust 
mite IgE ratio 
0.937 0.517  0.81 (0.74, 0.89) <0.001 
      
  No wheeze Wheeze    
       
SWA  IgE 1672 2627  1.15 (0.81, 1.64) 0.425 
 
IgG4 12753 14802  1.05 (0.71, 1.54) 0.808 
SEA  IgE 1636 1547  0.93 (0.66, 1.29) 0.662 
 
IgG4 81698 145978  1.16 (0.77, 1.73) 0.449 
House dust mite  IgE 2.8 26.6  1.35 (0.89, 2.04) 0.148 
 IgG4 0.007 0.008  0.85 (0.59, 1.25) 0.407 
 IgG4/IgE ratio 0.011 0.001  0.45 (0.22, 0.93) 0.032 
Cockroach IgE 21.2 2.9  0.69 (0.55, 0.87) 0.003 
 IgG4 0.021 0.006  0.65 (0.53, 0.82) 0.001 
 IgG4/IgE ratio 0.004 0.002  1.14 (0.47, 2.74) 0.760 
       
 Total IgE 1630 1522  0.88 (0.72, 1.07) 0.205 
 
Total IgG4 100983 74475  0.85 (0.61, 1.17) 0.302 
 
Total IgG4/ 
total IgE ratio 
61.00 47.36  0.95 (0.77, 1.18) 0.683 
 
Total IgE/ 
cockroach IgE 
ratio 
6.29 6.86  0.91 (0.78, 1.05) 0.187 
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Total IgE/ dust 
mite IgE ratio 
0.857 0.752  0.91 (0.77, 1.05) 0.188 
       
†
All antibody concentrations in ng/ml.  
‡
All geometric mean ratios and 95% confidence intervals adjusted for survey design, age and sex.  
¶
Geometric mean ratios and 95% confidence intervals for associations between antibody levels and SPT 
reactivity and wheeze were additionally adjusted for SmKK result. 
SWA: Schistosoma worm antigen; SEA: Schistosoma egg antigen; SmKK-: Kato-Katz negative result (S. 
mansoni), single stool sample; SmKK
+
: Kato-Katz positive result, single stool sample; aGMR: adjusted 
geometric mean ratio; 95% CI: 95% confidence interval. 
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Figure 1. Hypothesised contribution of S. mansoni-induced cytokines and antibodies to allergy-related outcomes 
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